Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Post by Polaris570on Jan 15, 2021 10:22pm
269 Views
Post# 32312356

Something interesting I found (Departures Capital)

Something interesting I found (Departures Capital)Departures Capital doesn't talk about Mydecine anymore! Watch the video at the 3:02 and 10:30 minute marks. Aaron from departures capital was asked why he doesn't talk about Mydecine Innovations anymore compared to Mind Med and Luminas. He admits selling his holdings from Mydecine to transfer into MMED and NUMI. 

https://www.youtube.com/watch?v=50Mf7csZ4Jc&t=662s

If you look at todays video of Departures Capital January 15 2921 Aaron seems depressed because MYCO was green and MMED and NUMI were red again. Aaron wanted to take profits from MMED and NUMI without success! 

Good luck to MYCO holders! Don't make the same mistake Departure Capital made.
<< Previous
Bullboard Posts
Next >>